Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (331-340 of 496) with videos related to

Pageof 50
Sort By:
Carcinogenesis|May 26, 2021
Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma researchShama Virani, Glauco Baiocchi, David Bowtell, et al.
Trials|March 3, 2011
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trialsMatthew Burnell, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2015
Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes MellitusClaire Jenkinson, Victoria L Elliott, Anthony Evans, et al.
Cancers|May 21, 2020
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and PreventionFaiza Gaba, Oleg Blyuss, Xinting Liu, et al.
BMJ (Clinical Research Ed.)|November 15, 2008
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive studyUsha Menon, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Gynecologic Oncology|October 24, 2025
Extracellular vesicle and particle-based blood test for ovarian cancer screening of average risk population: a promising nested case control study using preclinical samplesBrendan Manning, Sanchari Banerjee, Troy B Hawkins, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
BMJ Open|November 29, 2019
Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP)Usha Menon, Peter Vedsted, Alina Zalounina Falborg, et al.
Cancer Causes & Control : CCC|June 30, 2022
Cancer disparities in the context of rurality: risk factors and screening across various U.S. rural classification codesKelly A Hirko, Huiwen Xu, Laura Q Rogers, et al.
British Journal of Cancer|May 26, 2022
Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP)Usha Menon, David Weller, Alina Zalounina Falborg, et al.
Pageof 50

Showing results (331-340 of 496) with videos related to

Sort By:
Pageof 50
Carcinogenesis|May 26, 2021
Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma researchShama Virani, Glauco Baiocchi, David Bowtell, et al.
Trials|March 3, 2011
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trialsMatthew Burnell, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2015
Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes MellitusClaire Jenkinson, Victoria L Elliott, Anthony Evans, et al.
Cancers|May 21, 2020
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and PreventionFaiza Gaba, Oleg Blyuss, Xinting Liu, et al.
BMJ (Clinical Research Ed.)|November 15, 2008
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive studyUsha Menon, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Gynecologic Oncology|October 24, 2025
Extracellular vesicle and particle-based blood test for ovarian cancer screening of average risk population: a promising nested case control study using preclinical samplesBrendan Manning, Sanchari Banerjee, Troy B Hawkins, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
BMJ Open|November 29, 2019
Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP)Usha Menon, Peter Vedsted, Alina Zalounina Falborg, et al.
Cancer Causes & Control : CCC|June 30, 2022
Cancer disparities in the context of rurality: risk factors and screening across various U.S. rural classification codesKelly A Hirko, Huiwen Xu, Laura Q Rogers, et al.
British Journal of Cancer|May 26, 2022
Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP)Usha Menon, David Weller, Alina Zalounina Falborg, et al.
Pageof 50